E-Paper
Jubilant Life Sciences Q1 net up 22% at ₹162 cr
NEW DELHI: Jubilant Life Sciences on Tuesday posted a 22.48% rise in consolidated net profit at ₹161.60 crore for the quarter ended June, on robust sales in pharmaceuticals.
Published on: Aug 10, 2016, 06:44:18 IST
Share via
Copy link
NEW DELHI: Jubilant Life Sciences on Tuesday posted a 22.48% rise in consolidated net profit at ₹161.60 crore for the quarter ended June, on robust sales in pharmaceuticals. It had a net profit of ₹131.93 crore a year ago. “We have started the FY-17 on a positive note delivering strong performance in pharmaceuticals segment which contributed about 70% of the company’s operating profit,” chairman Shyam S Bhartia and co-chairman and MD Hari S Bhartia said in a statement.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
